News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Endo International (ENDP) Warns Of More Pressure On Generics Business In 2017



11/9/2016 7:19:04 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
Endo is facing increasing pricing and competitive pressures in its U.S. generics business and the trends will likely worsen in 2017, newly appointed Chief Executive Paul Campanelli said on Tuesday.

The warning overshadowed Endo's better-than-expected quarterly results that were driven by higher demand for its generic drugs, which accounts for about 60 percent of total revenue.

Endo's shares, which gained more than 4 percent in premarket trading, reversed course to close down nearly 7.5 percent at $14.51 on Tuesday.

Read at CNBC


comments powered by Disqus
CNBC
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES